Skip to main content
Top
Published in: Annals of Nuclear Medicine 7/2022

29-05-2022 | Original Article

Evaluation of physiological Waldeyer’s ring, mediastinal blood pool, thymic, bone marrow, splenic and hepatic activity with 18F-FDG PET/CT: exploration of normal range among pediatric patients

Authors: Geneviève April, Jean Jacques De Bruycker, Hélène Decaluwe, Elie Haddad, Raymond Lambert, Sophie Turpin

Published in: Annals of Nuclear Medicine | Issue 7/2022

Login to get access

Abstract

Introduction

While 18F-FDG PET/CT pediatrics applications have increased in number and indications, few studies have addressed normal maximum standardized uptake values (SUVmax) of referral organs in children. The purpose of this study is to assess these in a cohort of pediatric patients.

Material and methods

285 18F-FDG PET/CT scans in 229 patients were reviewed. SUVmax were assessed for mediastinal blood pool (MBP), thymus (T), liver (L), spleen (S), bone marrow (BM) and Waldeyer’s Ring (Wald). L/MBP and S/L ratios were calculated. Same day complete blood counts (CBC) were available for 132 studies and compared to BM and S. Means, standard deviations and correlation coefficients with age, weight and body surface area (BSA) were calculated.

Results

Weak correlation with age, weight or BSA was found for Wald. Strong correlations with weight/BSA more than with age were demonstrated for MBP, L and BM and moderate for S and T. After initial decrease between age 0 and 2, thymic activity peaked at age 11 years then involuted. No correlation was found between CBC ad BM or S. In 28 studies, L was less or equal to MBP. In 74 S was superior to L.

Conclusions

Referral organs 18F-FDG uptake varies in children more in relation with weight and BSA than with age for key referral organs, such as L, S and MBP. In a significant number of studies, L activity may impede evaluation of treatment response in comparison with MBP or inflammation/infection evaluation in comparison with S.
Literature
1.
go back to reference Stauss J, Franzius C, Pfluger T, et al. European Association of Nuclear Medicine. Guidelines for F-18-FDG PET and PET-CT imaging in paediatric oncology. Eur J Nucl Med Mol Imaging. 2008;35:1581–8.CrossRef Stauss J, Franzius C, Pfluger T, et al. European Association of Nuclear Medicine. Guidelines for F-18-FDG PET and PET-CT imaging in paediatric oncology. Eur J Nucl Med Mol Imaging. 2008;35:1581–8.CrossRef
2.
go back to reference Vali R, Alessio A, Balza R, et al. SNMMI procedure standard/EANM practice guideline on pediatric F-18-FDG PET/CT for oncology 1.0. J Nucl Med. 2021;62:99–110.CrossRef Vali R, Alessio A, Balza R, et al. SNMMI procedure standard/EANM practice guideline on pediatric F-18-FDG PET/CT for oncology 1.0. J Nucl Med. 2021;62:99–110.CrossRef
3.
go back to reference Boellaard R, Delgado-Bolton R, Oyen WJ, et al. European Association of Nuclear Medicine (EANM). FDG PET/CT: EANM procedure guidelines for tumour imaging: version 2.0. Eur J Nucl Med Mol Imaging. 2015;42:328–54.CrossRef Boellaard R, Delgado-Bolton R, Oyen WJ, et al. European Association of Nuclear Medicine (EANM). FDG PET/CT: EANM procedure guidelines for tumour imaging: version 2.0. Eur J Nucl Med Mol Imaging. 2015;42:328–54.CrossRef
4.
go back to reference Wahl RL, Jacene H, Kasamon Y, et al. From RECIST to PERCIST: evolving considerations for PET response criteria in solid tumors. J Nucl Med. 2009;50(Suppl 1):122S-S150.CrossRef Wahl RL, Jacene H, Kasamon Y, et al. From RECIST to PERCIST: evolving considerations for PET response criteria in solid tumors. J Nucl Med. 2009;50(Suppl 1):122S-S150.CrossRef
5.
go back to reference Kim K, Kim SJ, Kim IJ, et al. Diffuse increased splenic F-18 fluorodeoxyglucose uptake may be an indirect sign of acute pyogenic cause rather than tuberculous in patients with infectious spondylitis. Nucl Med Commun. 2011;32:1155–61.CrossRef Kim K, Kim SJ, Kim IJ, et al. Diffuse increased splenic F-18 fluorodeoxyglucose uptake may be an indirect sign of acute pyogenic cause rather than tuberculous in patients with infectious spondylitis. Nucl Med Commun. 2011;32:1155–61.CrossRef
6.
go back to reference Nanni C, Rubello D, Castellucci P, et al. 18F-FDG PET/CT fusion imaging in paediatric solid extracranial tumours. Biomed Pharmacother. 2006;60:593–606.CrossRef Nanni C, Rubello D, Castellucci P, et al. 18F-FDG PET/CT fusion imaging in paediatric solid extracranial tumours. Biomed Pharmacother. 2006;60:593–606.CrossRef
7.
go back to reference Agrawal A, Shah S, Gnanasegaran G, Rajkotia S, Purandare N, Puranik A, Rangarajan V. PET/CT normal variants and pitfalls in pediatric disorders. Semin Nucl Med. 2021;51:572–83.CrossRef Agrawal A, Shah S, Gnanasegaran G, Rajkotia S, Purandare N, Puranik A, Rangarajan V. PET/CT normal variants and pitfalls in pediatric disorders. Semin Nucl Med. 2021;51:572–83.CrossRef
8.
go back to reference Chen DS, Mellman I. Oncology meets immunology: the cancer-immunity cycle. Immunity. 2013;39:1–10.CrossRef Chen DS, Mellman I. Oncology meets immunology: the cancer-immunity cycle. Immunity. 2013;39:1–10.CrossRef
9.
go back to reference Dranoff G. Cytokines in cancer pathogenesis and cancer therapy. Nat Rev Cancer. 2004;4:11–22.CrossRef Dranoff G. Cytokines in cancer pathogenesis and cancer therapy. Nat Rev Cancer. 2004;4:11–22.CrossRef
10.
go back to reference Heiss WD, Herholz K, Pawlik G, Wagner R, Wienhard K. Positron emission tomography in neuropsychology. Neuropsychologia. 1986;24:141–9.CrossRef Heiss WD, Herholz K, Pawlik G, Wagner R, Wienhard K. Positron emission tomography in neuropsychology. Neuropsychologia. 1986;24:141–9.CrossRef
11.
go back to reference Sher A, Lacoeuille F, Fosse P, et al. For avid glucose tumors, the SUV peak is the most reliable parameter for ((18)F) FDG-PET/CT quantification, regardless of acquisition time. EJNMMI Res. 2016;6:21.CrossRef Sher A, Lacoeuille F, Fosse P, et al. For avid glucose tumors, the SUV peak is the most reliable parameter for ((18)F) FDG-PET/CT quantification, regardless of acquisition time. EJNMMI Res. 2016;6:21.CrossRef
12.
go back to reference Hasenclever D, Kurch L, Mauz-Körholz C, et al. qPET - a quantitative extension of the Deauville scale to assess response in interim FDG-PET scans in lymphoma. Eur J Nucl Med Mol Imaging. 2014;41:1301–8.CrossRef Hasenclever D, Kurch L, Mauz-Körholz C, et al. qPET - a quantitative extension of the Deauville scale to assess response in interim FDG-PET scans in lymphoma. Eur J Nucl Med Mol Imaging. 2014;41:1301–8.CrossRef
13.
go back to reference Blautzik J, Grelich L, Schramm N, et al. What and how should we measure in paediatric oncology FDG-PET/CT? Comparison of commonly used SUV metrics for differentiation between paediatric tumours. EJNMMI Res. 2019;9:115–24.CrossRef Blautzik J, Grelich L, Schramm N, et al. What and how should we measure in paediatric oncology FDG-PET/CT? Comparison of commonly used SUV metrics for differentiation between paediatric tumours. EJNMMI Res. 2019;9:115–24.CrossRef
14.
go back to reference Eskian M, Alavi A, Khorasanizadeh M, et al. Effect of blood glucose level on standardized uptake value (SUV) in F-18- FDG PET-scan: a systematic review and meta-analysis of 20,807 individual SUV measurements. Eur J Nucl Med Mol Imaging. 2019;46:224–37.CrossRef Eskian M, Alavi A, Khorasanizadeh M, et al. Effect of blood glucose level on standardized uptake value (SUV) in F-18- FDG PET-scan: a systematic review and meta-analysis of 20,807 individual SUV measurements. Eur J Nucl Med Mol Imaging. 2019;46:224–37.CrossRef
15.
go back to reference Meignan M, Gallamini A, Meignan M, et al. Report on the first international workshop on interim-PET-Scan in lymphoma. Leuk Lymphoma. 2009;50:1257–60.CrossRef Meignan M, Gallamini A, Meignan M, et al. Report on the first international workshop on interim-PET-Scan in lymphoma. Leuk Lymphoma. 2009;50:1257–60.CrossRef
16.
go back to reference Mejia AA, Nakamura T, Masatoshi I, et al. Estimation of absorbed doses in humans due to intravenous administration of fluorine-18-fluorodeoxyglucose in PET studies. J Nucl Med. 1991;32:699–706.PubMed Mejia AA, Nakamura T, Masatoshi I, et al. Estimation of absorbed doses in humans due to intravenous administration of fluorine-18-fluorodeoxyglucose in PET studies. J Nucl Med. 1991;32:699–706.PubMed
17.
go back to reference Hays MT, Watson EE, Thomas SR, et al. MIRD dose estimate report no. 19: radiation absorbed dose estimates from (18)F-FDG. J Nucl Med. 2002;43:210–4.PubMed Hays MT, Watson EE, Thomas SR, et al. MIRD dose estimate report no. 19: radiation absorbed dose estimates from (18)F-FDG. J Nucl Med. 2002;43:210–4.PubMed
18.
go back to reference Kubota K, Itoh M, Ozaki K, Ono S, Tashiro M, Yamaguchi K, Akaizawa T, Yamada K, Fukuda H. Advantage of delayed whole-body FDG-PET imaging for tumour detection. Eur J Nucl Med. 2001;28:696–703.CrossRef Kubota K, Itoh M, Ozaki K, Ono S, Tashiro M, Yamaguchi K, Akaizawa T, Yamada K, Fukuda H. Advantage of delayed whole-body FDG-PET imaging for tumour detection. Eur J Nucl Med. 2001;28:696–703.CrossRef
19.
go back to reference Cheng G, Alavi A, Lim E, Werner TJ, Del Bello CV, Akers SR. Dynamic changes of FDG uptake and clearance in normal tissues. Mol Imaging Biol. 2013;15:345–52.CrossRef Cheng G, Alavi A, Lim E, Werner TJ, Del Bello CV, Akers SR. Dynamic changes of FDG uptake and clearance in normal tissues. Mol Imaging Biol. 2013;15:345–52.CrossRef
20.
go back to reference Malladi A, Viner M, Jackson T, et al. PET/CT mediastinal and liver FDG uptake: effects of biological and procedural factors. J Med Imaging Radiat Oncol. 2013;57:169–75.CrossRef Malladi A, Viner M, Jackson T, et al. PET/CT mediastinal and liver FDG uptake: effects of biological and procedural factors. J Med Imaging Radiat Oncol. 2013;57:169–75.CrossRef
21.
go back to reference Groheux D, Delord M, Rubello D, et al. Variation of liver SUV on (18) FDG-PET/CT studies in women with breast cancer. Clin Nucl Med. 2013;38:422–5.CrossRef Groheux D, Delord M, Rubello D, et al. Variation of liver SUV on (18) FDG-PET/CT studies in women with breast cancer. Clin Nucl Med. 2013;38:422–5.CrossRef
22.
go back to reference Beath SV. Hepatic function and physiology in the newborn. Semin Neonatol. 2003;8:337–46.CrossRef Beath SV. Hepatic function and physiology in the newborn. Semin Neonatol. 2003;8:337–46.CrossRef
23.
go back to reference Suchy FL. Functional development of liver. In: Suchy FJ, Sokol RJ, Balistreri WF, editors. Liver disease in children. 4th ed. Cambridge: Cambridge University Press; 2014. p. 10–23.CrossRef Suchy FL. Functional development of liver. In: Suchy FJ, Sokol RJ, Balistreri WF, editors. Liver disease in children. 4th ed. Cambridge: Cambridge University Press; 2014. p. 10–23.CrossRef
24.
go back to reference Rini JN, Manalili EY, Hoffman MA, et al. F-18 FDG versus Ga-67 for detecting splenic involvement in Hodgkin’s disease. Clin Nucl Med. 2002;27:572–7.CrossRef Rini JN, Manalili EY, Hoffman MA, et al. F-18 FDG versus Ga-67 for detecting splenic involvement in Hodgkin’s disease. Clin Nucl Med. 2002;27:572–7.CrossRef
25.
go back to reference Pak K, Kim SJ, Kim IJ, et al. Impact of cytokines on diffuse splenic F-18-fluorodeoxyglucose uptake during positron emission tomography/computed tomography. Nucl Med Commun. 2013;34:64–70.CrossRef Pak K, Kim SJ, Kim IJ, et al. Impact of cytokines on diffuse splenic F-18-fluorodeoxyglucose uptake during positron emission tomography/computed tomography. Nucl Med Commun. 2013;34:64–70.CrossRef
26.
go back to reference Lyons K, Seghers V, Sorensen JI, et al. Comparison of standardized uptake values in normal structures between PET/CT and PET/MRI in a tertiary pediatric hospital: a prospective study. AJR Am J Roentgenol. 2015;205:1094–101.CrossRef Lyons K, Seghers V, Sorensen JI, et al. Comparison of standardized uptake values in normal structures between PET/CT and PET/MRI in a tertiary pediatric hospital: a prospective study. AJR Am J Roentgenol. 2015;205:1094–101.CrossRef
27.
go back to reference Yeung HW, Sanches A, Squire OD, et al. Standardized uptake value in pediatric patients: an investigation to determine the optimum measurement parameter. Eur J Nucl Med Mol Imaging. 2002;29:61–6.CrossRef Yeung HW, Sanches A, Squire OD, et al. Standardized uptake value in pediatric patients: an investigation to determine the optimum measurement parameter. Eur J Nucl Med Mol Imaging. 2002;29:61–6.CrossRef
28.
go back to reference Patel PM, Alibazoglu H, Ali A, et al. Normal thymic uptake of FDG on PET imaging. Clin Nucl Med. 1996;21:772–5.CrossRef Patel PM, Alibazoglu H, Ali A, et al. Normal thymic uptake of FDG on PET imaging. Clin Nucl Med. 1996;21:772–5.CrossRef
29.
go back to reference Brink I, Reinhardt MJ, Hoegerle S, et al. Increased metabolic activity in the thymus gland studied with F-18-FDG PET: age dependency and frequency after chemotherapy. J Nucl Med. 2001;42:591–5.PubMed Brink I, Reinhardt MJ, Hoegerle S, et al. Increased metabolic activity in the thymus gland studied with F-18-FDG PET: age dependency and frequency after chemotherapy. J Nucl Med. 2001;42:591–5.PubMed
30.
go back to reference Jerushalmi J, Frenkel A, Bar-Shalom R, et al. Physiologic thymic uptake of F-18-FDG in children and young adults: a PET/CT evaluation of incidence, patterns, and relationship to treatment. J Nucl Med. 2009;50:849–53.CrossRef Jerushalmi J, Frenkel A, Bar-Shalom R, et al. Physiologic thymic uptake of F-18-FDG in children and young adults: a PET/CT evaluation of incidence, patterns, and relationship to treatment. J Nucl Med. 2009;50:849–53.CrossRef
31.
go back to reference Gawande RS, Khurana A, Messing S, et al. Differentiation of normal thymus from anterior mediastinal lymphoma and lymphoma recurrence at pediatric PET/CT. Radiology. 2012;262:613–22.CrossRef Gawande RS, Khurana A, Messing S, et al. Differentiation of normal thymus from anterior mediastinal lymphoma and lymphoma recurrence at pediatric PET/CT. Radiology. 2012;262:613–22.CrossRef
32.
go back to reference Blebea JS, Houseni M, Torigian DA, et al. Structural and functional imaging of normal bone marrow and evaluation of its age-related changes. Semin Nucl Med. 2007;37:185–94.CrossRef Blebea JS, Houseni M, Torigian DA, et al. Structural and functional imaging of normal bone marrow and evaluation of its age-related changes. Semin Nucl Med. 2007;37:185–94.CrossRef
33.
go back to reference Inoue K, Goto R, Okada K, et al. A bone marrow F-18 FDG uptake exceeding the liver uptake may indicate bone marrow hyperactivity. Ann Nucl Med. 2009;23:643–9.CrossRef Inoue K, Goto R, Okada K, et al. A bone marrow F-18 FDG uptake exceeding the liver uptake may indicate bone marrow hyperactivity. Ann Nucl Med. 2009;23:643–9.CrossRef
34.
go back to reference Adams HJ, de Klerk JM, Fijnheer R, et al. Variety in bone marrow F-18-FDG uptake in Hodgkin lymphoma patients without lymphomatous bone marrow involvement: does it have an explanation? Nucl Med Commun. 2016;37:23–9.CrossRef Adams HJ, de Klerk JM, Fijnheer R, et al. Variety in bone marrow F-18-FDG uptake in Hodgkin lymphoma patients without lymphomatous bone marrow involvement: does it have an explanation? Nucl Med Commun. 2016;37:23–9.CrossRef
35.
go back to reference Okuyama C, Matsushima S, Nishimura M, Yamada K. Increased 18F-FDG accumulation in the tonsils after chemotherapy for pediatric lymphoma: a common physiological phenomenon. Ann Nucl Med. 2019;33:368–73.CrossRef Okuyama C, Matsushima S, Nishimura M, Yamada K. Increased 18F-FDG accumulation in the tonsils after chemotherapy for pediatric lymphoma: a common physiological phenomenon. Ann Nucl Med. 2019;33:368–73.CrossRef
36.
go back to reference Song H, Guja KE, Iagaru A. 18F-FDG PET/CT for evaluation of post-transplant lymphoproliferative disorder (PTLD). Semin Nucl Med. 2021;51:392–403.CrossRef Song H, Guja KE, Iagaru A. 18F-FDG PET/CT for evaluation of post-transplant lymphoproliferative disorder (PTLD). Semin Nucl Med. 2021;51:392–403.CrossRef
Metadata
Title
Evaluation of physiological Waldeyer’s ring, mediastinal blood pool, thymic, bone marrow, splenic and hepatic activity with 18F-FDG PET/CT: exploration of normal range among pediatric patients
Authors
Geneviève April
Jean Jacques De Bruycker
Hélène Decaluwe
Elie Haddad
Raymond Lambert
Sophie Turpin
Publication date
29-05-2022
Publisher
Springer Nature Singapore
Published in
Annals of Nuclear Medicine / Issue 7/2022
Print ISSN: 0914-7187
Electronic ISSN: 1864-6433
DOI
https://doi.org/10.1007/s12149-022-01748-2

Other articles of this Issue 7/2022

Annals of Nuclear Medicine 7/2022 Go to the issue